Kailos

Huntsville, United States Founded: 2010 • Age: 16 yrs Acquired By HealthOme
Provider of consumer-based genetic testing services
Request Access

About Kailos

Kailos is a company based in Huntsville (United States) founded in 2010 was acquired by HealthOme in June 2023.. Kailos has raised $3.9 million across 4 funding rounds from investors including NIH, healthŌme and In-Q-Tel. The company has 10 employees as of December 31, 2022. Kailos offers products and services including Precision Medicine Sequencing Panels, TargetRich Enrichment Technology, and Reagents and Services. Kailos operates in a competitive market with competitors including Helix, Color, Veritas Genetics, Counsyl and GreenLight Biosciences, among others.

  • Headquarter Huntsville, United States
  • Employees 10 as on 31 Dec, 2022
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Kailos Genetics, Inc.
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research
Healthcare → Biotechnology, Genomics & Life Sciences Research
Healthcare → Health Technology & Digital Health
Key Metrics
  • Annual Revenue
    $0
    0
    as on Nov 16, 2016
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $3.9 M (USD)

    in 4 rounds

  • Latest Funding Round
    $2 M (USD), Series B

    Apr 22, 2022

  • Investors
    NIH

    & 2 more

  • Employee Count
    10

    as on Dec 31, 2022

  • Acquired by
    HealthOme

    (Jun 01, 2023)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Kailos

Kailos offers a comprehensive portfolio of products and services, including Precision Medicine Sequencing Panels, TargetRich Enrichment Technology, and Reagents and Services. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Customizable panels for integrating into laboratory workflows.

Technology for enhanced genetic sequencing and analysis.

Complete kits for genetic research and data analysis.

People of Kailos
Headcount 10-50
Employee Profiles 7
Employee Profiles
People
Ron McGlennen
Medical Director
People
Brian Pollock
CEO & Founder
People
David Kloske
VP of Informatics & Chief Technology Officer
People
Irina Vasenkova PhD, HCLD/TS(ABB)
Clinical Laboratory Assistant Director

Unlock access to complete

Funding Insights of Kailos

Kailos has successfully raised a total of $3.9M across 4 strategic funding rounds. The most recent funding activity was a Series B round of $2 million completed in April 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 4
  • Last Round Series B — $2.0M
  • First Round

    (16 Dec 2011)

  • Investors Count 2
Date Amount Transaction Name Valuation Lead Investors Investors
Apr, 2022 Amount Series B - Kailos Valuation

investors

Jul, 2017 Amount Series B - Kailos Valuation

investors

Jun, 2016 Amount Grant - Kailos Valuation

investors

NIH
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Kailos

Kailos has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include NIH, healthŌme and In-Q-Tel. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Venture capital firm
Founded Year Domain Location
Drug discovery services are provided to the biopharma sector.
Founded Year Domain Location
Genetic testing and support services for cancer risks are provided.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Kailos

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Kailos

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Kailos Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Kailos

Kailos operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Helix, Color, Veritas Genetics, Counsyl and GreenLight Biosciences, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Genomic database for clinical research is provided.
domain founded_year HQ Location
Cancer care is delivered through a virtual clinic by Color.
domain founded_year HQ Location
Genetic testing products for health risks and traits are offered.
domain founded_year HQ Location
DNA mapping for pre-pregnancy genetic testing, DNA and cancer screening
domain founded_year HQ Location
RNA-based platform for life sciences is developed by GreenLight Biosciences.
domain founded_year HQ Location
Provider of direct-to-consumer genetic testing.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Kailos

Frequently Asked Questions about Kailos

When was Kailos founded?

Kailos was founded in 2010 and raised its 1st funding round 1 year after it was founded.

Where is Kailos located?

Kailos is headquartered in Huntsville, United States. It is registered at Huntsville, Alabama, United States.

Is Kailos a funded company?

Kailos is a funded company, having raised a total of $3.9M across 4 funding rounds to date.

How many employees does Kailos have?

As of Dec 31, 2022, the latest employee count at Kailos is 10.

What does Kailos do?

Founded in 2010 and headquartered in Huntsville, United States, operations in the biotechnology sector are focused on consumer genetic testing. Clinical-grade assays and next-generation sequencing are utilized to deliver actionable genetic insights. Services encompass cancer testing, pharmacogenetic analysis, and research support, enabling personalized health information for individuals and studies.

Who are the top competitors of Kailos?

Kailos's top competitors include GreenLight Biosciences, Helix and Veritas Genetics.

What products or services does Kailos offer?

Kailos offers Precision Medicine Sequencing Panels, TargetRich Enrichment Technology, and Reagents and Services.

Who are Kailos's investors?

Kailos has 3 investors. Key investors include NIH, healthŌme, and In-Q-Tel.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available